Form 8-K - Current report:
SEC Accession No. 0001193125-20-086927
Filing Date
2020-03-26
Accepted
2020-03-26 16:06:56
Documents
3
Period of Report
2020-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d140983d8k.htm 8-K 35034
2 EX-99.1 d140983dex991.htm EX-99.1 9549
3 GRAPHIC g140983image_001a.jpg GRAPHIC 2152
  Complete submission text file 0001193125-20-086927.txt   48934
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 20746204
SIC: 2834 Pharmaceutical Preparations